Pearls & Oy-sters: Primary Diffuse Leptomeningeal Melanocytosis: A Diagnostic Conundrum

Jeevi Mona Priyadharshni Selvarajan1, Sridhar Epari1, Arpita Sahu1

  • 1From the Departments of Radiation Oncology (J.M.P.S., A.D., A.C., T.G.), Pathology (S.E.), and Radio-diagnosis (A.S.), Tata Memorial Hospital (TMH)/Advanced Centre for Treatment Research & Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.

Neurology
|March 6, 2023
PubMed

Insights

Primary diffuse leptomeningeal melanocytosis (PDLM) is a rare CNS tumor often misdiagnosed as meningitis. This case highlights diagnostic challenges and successful craniospinal irradiation treatment for PDLM.

Area of Science:

  • Neuro-oncology
  • Rare CNS Tumors

Background:

  • Primary diffuse leptomeningeal melanocytosis (PDLM) presents with nonspecific symptoms, mimicking aseptic meningitis.
  • Diagnostic challenges arise from overlapping clinicoradiologic features with other CNS conditions.

Observation:

  • A patient initially treated for aseptic viral meningitis based on MRI and CSF analysis.
  • Subsequent meningeal biopsy confirmed PDLM, revealing a melanocytic tumor with melanin pigment.

Findings:

  • The patient underwent ventriculoperitoneal shunting for hydrocephalus.
  • Definitive treatment included craniospinal irradiation with a whole-brain boost, resulting in stability.

Implications:

  • This case underscores the importance of considering PDLM in differential diagnoses.
  • Optimal management strategies for PDLM remain controversial, necessitating further research into radiotherapy, chemotherapy, and novel therapies.

Related Concept Videos